Pain relief study for cancer patients with moderate to severe pain
Treatments studied
Part of Pain clinical trials.
This study tests whether a new pain medication called 3D1002, when combined with a long-acting opioid, can better manage moderate to severe cancer pain compared to the opioid alone. The goal is to find a more effective way to reduce pain without increasing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old and weigh at least 40 kg (about 88 pounds).
- You need a confirmed cancer diagnosis that is causing moderate to severe pain.
- Your pain must be stable enough that you take painkillers regularly and expect to need them for at least 2 more weeks.
- You should be in generally good health, with a life expectancy of at least 3 months.
- You must be able to stop taking other pain medications (except the study drugs) during the study period.
- You must not have had a recent stroke, serious heart problems, or bleeding in your stomach or intestines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding non-opioid pain relievers (like dipyrone or ibuprofen) to your usual opioid pain medication can better control cancer pain. It aims to see if the combination is more effective and safe.
This study tests how well and how safely OxyContin, a pain medicine, works when started at home (outpatient) for people with moderate to severe cancer pain. It aims to help patients manage pain more easily while staying at home.
This trial tests whether a special website or app can help people with cancer do a better job managing their pain. If you have moderate or severe cancer pain that needs morphine and you can use a simple app to track your symptoms, this may help you feel better.
This trial tests a new injection called sss40 to treat moderate-to-severe pain caused by cancer that has spread to the bones. The goal is to see if it is safe and effective for people whose pain is not being controlled by current treatments.
This trial tests a topical herbal plaster to see if it can help reduce pain in people with cancer who are already taking opioids. The plaster is placed on the most painful area and may allow you to use less opioid medication.
This study tests whether adding electroacupuncture (a treatment using mild electric pulses on needles) and ear acupressure (pressing on specific points on the ear) to the pain medicine hydromorphone helps reduce cancer-related pain that isn't well managed by usual treatments.
Hear when a new Cancer Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.